Esther Torres to Ribavirin
This is a "connection" page, showing publications Esther Torres has written about Ribavirin.
Connection Strength
0.874
-
Iturrino J, S?nchez CJ, Ortiz A, Romero CJ, Vel?zquez V, Costas P, Torres EA. Outcomes of an underserved Hispanic population with chronic hepatitis C treated with pegylated-interferon and ribavirin in a government-sponsored clinic. P R Health Sci J. 2011 Mar; 30(1):9-13.
Score: 0.387
-
Costas P, Ortiz A, Vel?zquez V, Torres EA. A government sponsored clinic for the evaluation and treatment of chronic hepatitis C in an underinsured population in Puerto Rico. P R Health Sci J. 2004 Jun; 23(2 Suppl):41-7.
Score: 0.243
-
Morales-V?squez L, Miranda-Avalo EI, Rodr?guez-Medina JR, Qui?ones-Badillo Y, Marqu?s-Lespier J, Mu?oz-Acab? J, Pastrana R, P?rez-Cardona CM, Yamamura Y, Torres EA. Demographics, clinical characteristics, IFNL3- and IFNL4- polymorphisms in a cohort of hepatitis C patients from Puerto Rico. P R Health Sci J. 2014 Dec; 33(4):177-83.
Score: 0.126
-
Mu?oz H, Arroyo J, Torres EA, De Jesus-Monge WE, Chinea B, Gonz?lez H, Aponte N, Guzm?n A, Rivera C, Rodr?guez F, Toro DH. Response to combination therapy of interferon alfa-2b plus ribavirin in Hispanics with chronic hepatitis C. P R Health Sci J. 2004 Jun; 23(2 Suppl):61-7.
Score: 0.061
-
Gonz?lez H, R?os ME, Torres EA, Mu?oz H, Arroyo J, Castro FJ. Folic acid supplementation does not prevent ribavirin-induced anemia. P R Health Sci J. 2003 Dec; 22(4):359-62.
Score: 0.059